The Travel Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Travel Vaccines Global Market Report 2024 market exhibited a strong growth trend recently. The market size is projected to increase from $4.73 billion in 2024 to $5.14 billion in 2025, representing a compound annual growth rate (CAGR) of 8.6%.
The Travel Vaccines Global Market Report 2024 predicts that by 2029, the market size for travel vaccines will grow to $7.49 billion, with a compound annual growth rate (CAGR) of 9.9%.
Download Your Free Sample of the 2025 Travel Vaccines Market Report and Uncover Key Trends Now!The key drivers in the travel vaccines market are:
• Increase in frequency of business travel
• Threats of emerging infectious diseases
• Government regulations and entry requirements
• Collaboration between governments and pharmaceutical companies
The travel vaccines market covered in this report is segmented –
1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel
The key trends in the travel vaccines market are:
• Tailored vaccination strategies are emerging as a significant trend.
• The market is expanding to non-endemic regions.
• The adoption of digital health technologies is on the rise.
• Regulatory support and streamlined approvals are shaping the future of the market.
The major players in the travel vaccines market are:
• Pfizer Inc
North America was the largest region in the travel vaccines market in 2024